What are the typical demographics and pertinent history associated with hyperosmolar hyperglycemic non‑ketotic syndrome (HHS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Demographics and Pertinent History of Hyperosmolar Hyperglycemic Syndrome

HHS predominantly affects elderly patients with type 2 diabetes, typically presenting in individuals over 60-70 years of age, often with poor diabetes management or undiagnosed diabetes, and is most commonly triggered by infection. 1

Key Demographics

Age Distribution

  • Median age: 63-75 years, with the condition particularly affecting the elderly population 2, 3
  • Extremes of age are associated with substantially worse prognosis and higher mortality 1
  • In pediatric cases (rare), age ranges from 6-16 years, with 67% younger than 13 years 4

Diabetes Type

  • Primarily occurs in type 2 diabetes patients 1
  • However, incidence rates show 16.5 per 10,000 person-years in type 1 diabetes versus 3.9 per 10,000 person-years in type 2 diabetes 5
  • 32% of HHS patients have no prior diabetes diagnosis - HHS can be the presenting manifestation of diabetes 5
  • In pediatric cases, subsequent diagnosis includes both type 1 and type 2 diabetes 4

Body Habitus

  • Variable BMI presentation - not limited to obese patients 4
  • In elderly Japanese cohort, mean BMI was notably low at 17.8 kg/m² 6

Race/Ethnicity

  • In pediatric cases, 83% were African-American 4

Pertinent Historical Features

Temporal Evolution

HHS evolves over several days to weeks (unlike DKA which develops within 24 hours) 1

Classic Symptom Constellation

  • Polyuria, polydipsia, polyphagia
  • Weight loss
  • Progressive dehydration and weakness
  • Altered mental status progressing to stupor/coma (more frequent in HHS than DKA) 1
  • Notably ABSENT: abdominal pain and vomiting (these occur in DKA, not typically in pure HHS) 1

Precipitating Factors (in order of frequency)

Most Common Triggers:

  1. Infection (44-51%) - particularly urinary tract infections and pneumonia 1, 2, 3
  2. Non-infectious acute illness (49.5%) 2
  3. New diabetes diagnosis (31.7%) 2

Other Important Precipitants:

  • Cerebrovascular accident
  • Myocardial infarction
  • Pancreatitis
  • Trauma
  • Medication-related:
    • Corticosteroids
    • Thiazide diuretics
    • Sympathomimetic agents (dobutamine, terbutaline) 1

Medication History

Critical finding: Approximately 70% of HHS patients were not receiving diabetes medications 3

Social and Functional History (Particularly in Elderly)

High-risk social situations:

  • Elderly individuals in chronic care facilities 1
  • Living alone or only with spouse (>50% of cases) 6
  • Patients unable to access fluids independently 1
  • Marked ADL deterioration 6
  • History of dementia (most HHS patients) 6

Past Medical History Red Flags

  • History of cerebral infarction or hip fracture (50% of elderly cases) 6
  • Comorbidities significantly increase risk (AHR: 3.01) 7
  • Mean diabetes duration: 14 years in those with known diabetes 6

Geographic and Seasonal Patterns

  • Seasonal peak in winter months 6
  • Rural residents have twice the risk (AHR: 1.99) 7

Healthcare Access Issues

  • Lack of community health insurance doubles risk (AHR: 2.04) 7
  • Medication non-adherence more than doubles risk (AHR: 2.14) 7

Clinical Pitfalls

Common diagnostic delays occur because:

  • 60% of outpatient cases are initially misdiagnosed, with some patients seen twice before accurate diagnosis 4
  • Patients may be normothermic or even hypothermic despite infection (hypothermia is a poor prognostic sign) 1
  • The insidious onset over days to weeks can mask the severity

Mortality considerations:

  • Overall mortality: 15-21% 1, 2
  • Pure HHS has 17% in-hospital mortality versus 9% for mixed HHS-DKA 5
  • Isolated HHS with metabolic acidosis: 54.6% 30-day mortality 3
  • Mortality varies dramatically by region: 40% in Africa, 18.2% in Asia, 4.8% in North America 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.